The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis.
Zhang Y, Xu X, Yang K, Wang S, Zhang T, Hui F, Zheng F, Geng H, Xu C, Xun F, Xu Z, Wang C, Hou S, Song A, Ren T, Zhao Q.
Zhang Y, et al. Among authors: xu c, xu x, xu z.
Eur J Pharmacol. 2024 Nov 15;983:176952. doi: 10.1016/j.ejphar.2024.176952. Epub 2024 Aug 30.
Eur J Pharmacol. 2024.
PMID: 39216745